Author | Jon Matthew Farber, MD


Can fewer daily doses of cephalexin treat MSSA?

June 03, 2020


A pharmacokinetic model suggests that although 4 daily doses of cephalexin are the standard of care for treating methicillin-susceptible Staphylococcus aureus (MSSA) infections, 2- or 3-dose daily regimens (BID or TID) could achieve similar results.

Excessive parental cell phone use is tied to mealtime problems

June 02, 2020


Children are more likely to exhibit troublesome behaviors during meals if their caregivers’ use of mobile phones is “problematic,” according to a study of 84 caregivers and their children.

PPI exposure increases risk of fractures

June 01, 2020


Children who take proton pump inhibitors (PPIs) are at increased risk of having fractures compared with those who have no PPI exposure, according to a retrospective review of information in the Pediatric Hospital Information System database. Further, likely fracture location differs between those who are exposed to PPIs and those who are not.

Paternal smoking raises risk of acute lymphoblastic leukemia

May 07, 2020


Paternal smoking before conception or during pregnancy are both associated with increased risk of acute lymphoblastic leukemia in offspring, and the risk is significant when daily smoking consumption is higher than a certain threshold, according to a recent meta-analysis.